Items where authors include "Mell, T."

Article

Sun, G., Fenton, H., Fuller, H. et al. (9 more authors) (2025) Understanding mechanisms of colorectal cancer chemoprevention using seAFOod polyp prevention trial outcomes and its Biobank: STOP-ADENOMA synopsis (Award ID NIHR128210). NIHR Open Research. ISSN 2633-4402 (In Press)

Sun, G., Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. et al. (7 more authors) (2024) APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial. Prostaglandins Leukotrienes and Essential Fatty Acids, 201. 102623. ISSN 0952-3278

Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207

Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207